Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

Maria Laura Acosta Felquer; Laura C Coates; Enrique R Soriano; Roberto Ranza; Luis R Espinoza; Philip S Helliwell; Oliver FitzGerald; Neil McHugh; Euthalia Roussou; Philip J Mease

doi:10.3899/jrheum.140876

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review

J Rheumatol. 2014 Nov;41(11):2277-85. doi: 10.3899/jrheum.140876.

Affiliation

¹ From the Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires; Academic Unit of Rheumatology, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA; Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College, Dublin, Ireland; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK; Barking Havering and Redbridge University Hospitals, NHS Trust; and Queens Mary's University of London, London, UK; and Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA.M.L. Acosta Felquer, MD, Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires; L.C. Coates, MRCP, PhD, NIHR Clinical Lecturer, Leeds Institute; E.R. Soriano, MD, MSC, Jefe Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires; R. Ranza, MD, Academic Unit of Rheumatology, Universidade Federal de Uberlândia; L.R. Espinoza, MD, Section of Rheumatology, Louisiana State University Health Sciences Center; P.S. Helliwell, DM, PhD, Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital; O. FitzGerald, MD, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College; N. McHugh, FRCP, MD, Department of Pharmacy and Pharmacology, University of Bath; E. Roussou, MD, Consultant Rheumatologist, Barking Havering and Redbridge University Hospitals, NHS Trust and Clinical Senior Lecturer, Queens Mary's University of London; P.J. Mease, MD, Rhe

PMID: 25362711
DOI: 10.3899/jrheum.140876

Abstract

In 2009, GRAPPA published their first evidence-based recommendations for the treatment of psoriasis and psoriatic arthritis (PsA). Since then, new information has been published and drugs developed. We summarize evidence for the efficacy of available treatments for peripheral joint involvement in PsA. We performed a systematic review of current literature on the efficacy of different therapies, management, and therapeutic strategies for peripheral arthritis involvement in PsA, in order to provide information for the development of the new GRAPPA treatment recommendations.

Keywords: BIOLOGICS; DISEASE MODIFYING ANTIRHEUMATIC DRUGS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; THERAPEUTIC STRATEGIES; TUMOR NECROSIS FACTOR INHIBITORS.

Publication types

Review
Systematic Review

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Antirheumatic Agents / therapeutic use
Arthritis, Psoriatic / diagnosis
Arthritis, Psoriatic / drug therapy*
Arthritis, Psoriatic / epidemiology*
Biological Products / therapeutic use
Comorbidity
Drug Therapy, Combination
Evidence-Based Medicine
Female
Follow-Up Studies
Humans
Injections, Intra-Articular
Joint Diseases / diagnosis
Joint Diseases / drug therapy*
Joint Diseases / epidemiology*
Male
Practice Guidelines as Topic*
Randomized Controlled Trials as Topic
Severity of Illness Index
Treatment Outcome

Substances

Adrenal Cortex Hormones
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Biological Products